NumerixS Investment Technologies’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

NumerixS Investment Technologies’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,800	Closed	-$208K	–	1524
2018 Q3	$208K	Buy	3,800 +3,600	+1,800%	+$246K	0.04%	572
2018 Q2	$17K	Buy	+200	New	+$15.4K	﹤0.01%	1029
2017 Q4	–	Sell	-200	Closed	-$18K	–	1450
2017 Q3	$18K	Sell	200 -3,300	-94%	-$251K	﹤0.01%	1064
2017 Q2	$209K	Buy	3,500 +1,500	+75%	+$83.8K	0.03%	627
2017 Q1	$107K	Sell	2,000 -1,200	-38%	-$71.2K	0.01%	872
2016 Q4	$160K	Buy	+3,200	New	+$171K	0.02%	748
2015 Q3	–	Sell	-5,800	Closed	-$350K	–	838
2015 Q2	$350K	Buy	+5,800	New	+$383K	0.05%	459

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

NumerixS Investment Technologies's ONCE Position: Q4 2018 in Review

NumerixS Investment Technologies sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2018, closing a stake of 3,800 shares — an estimated $208K sold.

NumerixS Investment Technologies first reported a position in ONCE in Q2 2015 and held it in 7 quarters. The position peaked at $350K in Q2 2015. 157 funds tracked by Wall St. Rank hold ONCE as of Q4 2018.

NumerixS Investment Technologies reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
NumerixS Investment Technologies sold 3,800 Spark Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $208K.
NumerixS Investment Technologies first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 7 quarters.
NumerixS Investment Technologies's Spark Therapeutics, Inc. Common Stock position peaked at $350K in Q2 2015.
157 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2018.

Based on NumerixS Investment Technologies's 13F filing for Q4 2018, filed 12 Feb 2019.